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Abstract The aim of this study was to investigate the annual
death trends for gastrointestinal cancer in Hungary between
1963 and 2012. Data on the numbers of cancer deaths were
obtained from the published nationwide population register.
Numbers of deaths from esophageal, gastric and colorectal
cancer were available during the study period. However, the
mortality data for hepatic, pancreatic and gallbladder cancer
have been published only since 1979. Joinpoint regression
was applied to investigate the annual trends in the rates of
cancer mortality. The annual mortality rates of gastric and
gallbladder cancer decreased throughout the study period.
Furthermore, declines in mortality from esophageal and he-
patic cancers have been observed since 1998 and 1995, re-
spectively. However, the rates of colorectal and pancreatic
cancer mortality have been increasing in the past few years.
Nevertheless, the mortality rates of colorectal and pancreatic
cancers have increased in males aged 40–59 years during the
study period. Moreover, significantly higher risks of gastroin-
testinal cancer-related deaths have been observed in males as
compared with females except for death related to cancer of
the gallbladder. The presented data suggest that the Hungarian
mortality rates are particularly high. The detection of gastro-
intestinal cancers at an early stage would significantly im-
proves the outcome of these malignancies.
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Introduction
Colorectal cancer is the third most common cancer worldwide
in men and the second most common in women, with 1.3
million new cases every year [1]. Gastrointestinal cancers
are common in both genders in Hungary, accounting for 10,
878 deaths (34.4 % of all cancer deaths) in the country in 2012
[2]. The Hungarian mortality rates for colorectal and pancre-
atic cancer were the highest and the second highest among
men in Europe in 2012, respectively [3]. Moreover, higher
mortality rates were also reported for gallbladder, esophageal
and liver cancer in Hungary than in other members countries
of the European Union [3, 4].
The worldwide rank of Hungarian mortality rate from can-
cer was 19th in 2008 [5], which was slightly better than in the
mid-1990s [6, 7].
The trends of annual mortality rates of gastrointestinal can-
cers overall or broken down by gender have not been investi-
gated in a complex manner in Hungary: only descriptive an-
nual mortality rates of gastrointestinal cancers have been re-
ported, and there have been no publications on trends (espe-
cially segmented linear trends) by gender or age groups.
The aim of the epidemiological study reported here was to
investigate the trends in the annual Hungarian mortality rates
from gastrointestinal cancers and to estimate the risk of mor-
tality by gender through the use of statistically internationally
comparable risk measurements of the patterns of mortality
from gastrointestinal cancers in Hungary.
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Material and Methods
Study Population
Two periods were considered in the analyses. Data on the num-
bers of population and deaths from esophageal, gastric and colo-
rectal cancer were available between 1 January 1963 and 31
December 2012 from the published nationwide population reg-
istry of the Hungarian Central Statistical Office [2]. Mortality
data on hepatic, pancreatic and gallbladder cancer have been
published since 1979, and thus the period between 1 January
1979 and 31 December 2012 was used in the analyses [2].
The data concerning the cause of deaths are published an-
nually by the Central Statistical Office. Although the
International Classification of Diseases (ICD) coding has
changed, mortality data on all of the above-detailed gastroin-
testinal cancers were published during the study period.
The ICD-10 codes were applied to classify the following
categories of malignant neoplasms of digestive organs in the
study: malignant neoplasms of the esophagus (C15), stomach
(C16), colorectum (C18–21), liver (C22), gallbladder (C23)
and pancreas (C25).
Data on both the numbers of the population and the num-
bers of cancer-related deaths were classified by age groups as
follows: 0–14 years, 15–39 years, 40–59 years, 60–69 years,
70–79 years and over 80 years or above. Thus, age-
standardized mortality rates (ASMRs) per 100,000 person-
years were calculated, using the standard world population
for comparison.
Since the numbers of deaths in the group aged 0–14 years
were too small, all analyses were carried out with the omission
of this group.
Statistical Methods
Investigation of Annual Trends
The ASMRs were used to investigate trends in mortality rates
for gastrointestinal cancers in Hungary during the study
period.
Trends were investigated using negative binomial regres-
sion models in analyses by gender, age group and type of
gastrointestinal cancer. Relative risks (RRs) and 95 % confi-
dence intervals (95 % CIs) were calculated. Joinpoint (JP)
regression analyses were additionally applied to characterize
trends and to find turning points during the study periods. JP
analyses were performed with the joinpoint regression soft-
ware (version 4.0.4) from the Surveillance Research Program
of the US National Cancer Institute.
The p-values less than 0.05 were considered to be
statistically significant. All analyses were carried out
with STATA Software version 9.0 (Stata Corp LP,
College Station, Texas, USA).
Results
Overall, 23,164 esophageal, 159,265 gastric, 193,432
colorectal, 31,526 liver, 32,015 gallbladder and 52,361
pancreatic cancer-related deaths were registered in
Hungary during the study period. Colorectal cancer
was the most common cause of death (Table 1) and
the highest ASMR of 25.01 per 100,000 persons-years
(95%CI 24.89–25.13) was also detected in case of colorectal
cancer (Table 1). Table 1 summarizes the ASMRs of gastro-
intestinal cancers overall and by gender during the study pe-
riod. The ASMRs of esophageal, gastric, colorectal, liver,
gallbladder and pancreatic cancers in 2012 were 7.83, 20.27,
58.03, 10.15, 6.59 and 22.29 per 100,000 persons per year,
respectively (Fig. 1a-f).
The highest ASMRs of gastrointestinal cancers were
observed in the group between the age of 70 and 79
except for the mortality rates of esophageal cancer being
the highest in the group aged 40–59 years (Table 1).
However, high mortality rates of gastric, colorectal and
pancreatic cancer were found in groups aged 40–
59 years and 60–69 years which were more marked in
males (Table 1).
Furthermore, significantly higher risks of deaths from
gastrointestinal cancer were detected in males as com-
pared with females in all types of cancers except death
from cancer of the gallbladder. The estimated risks of
mortality for male cases with 95 % CIs are given in
Table 2. Risk estimates of deaths from gastrointestinal
cancer highlighted a more than twice as great a risk in
males than in females for hepatic and gastric cancers
and a more than seven-fold risk for esophageal cancer.
Mortality Rates and Annual Trends Between 1963
and 2012
The average ASMRs of esophageal cancer varied be-
tween 3.11 (1973) and 11.41 (1998) in the population
older than 14 years between the period 1963–2012
(Fig. 1a). Overall, the JP regression model fitted a seg-
mented line indicating two main changes in the trend:
after a small decrease in the period between 1963 and
1971 a peak was observed in 1998 and then a signifi-
cant decrease was monitored. A significantly increasing
linear trend followed the decrease between 1963 and
1971 in the mortality with a break point in 1990 yield-
ing two periods as 1971–1990 and 1990–1998, and then
a significant decline between 1998 and 2012 (the slopes
of the four segments: −0.03 (p = 0.02), −0.06
(p < 0.001), 0.02 (p = 0.002) and −0.02 (p < 0.001),
respectively. Similar trends were observed among men
in the gender-specific analyses, but in women between
two basically constant periods a significant increase was
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detected between 1984 and 2000 with a slope of 0.05
(p < 0.001) (Fig. 2a).
A decreasing trend was observed with four segments in
ASMRs of gastric cancer which were as follows: 1963–1978
(slope: −0.018, p < 0.001), 1978–1986 (slope: −0.044,
p < 0.001), 1986–1990 (slope: 0.003, p = .90) and 1990–
2012 (slope: −0.036, p < 0.001) (Fig. 1b). Although, the mor-
tality rates were significantly higher in males than in females,
they decreased significantly between 1963 and 2012 (Fig. 2b).
Moreover, the mortality rates revealed also a decreasing pat-
tern in all age groups during the study period.
In the mortality rates of colorectal cancer, a significant,
approximately 3 % annual increase was revealed until 1978
and a 1.5 % increase was then observed until the peak in 1998,
followed by a significant decrease until 2006, and a basically
constant period thereafter (Fig. 1c). The annual changes in the
percentages, the slopes with p values of each segment were
3.17 %, 0.03 (p < 0.001); 1.49 %, 0.01 (p < 0.001), 1.51 %,
−0.02 (p < 0.001) and 0.36 %, 0.04 (p = 0.48), respectively.
Similar trends were observed in the male mortality rates for
colorectal cancer (Fig. 2c). However, the female mortality
rates of colorectal cancer increased until 1997 and then
Table 1 The number of deaths and the age-standardized mortality rates overall and by gender in Hungary during the study period
1963–2012 1979–2012
Esophegal Gastric Colorectal Hepatic Cancer of pancreatic
cancer cancer cancer cancer gallbladder cancer
OVERALL Number of deaths Number of deaths
23,164 159,265 193,432 31,526 32,015 52,361
Age
0–14 0.00 0.01 0.01 0.02 0.00 0.00
15–39 0.06 0.48 0.58 0.10 0.03 0.13
40–59 1.65 4.60 5.25 1.09 0.69 1.86
60–69 0.89 5.60 6.30 1.16 1.01 1.82
70–79 0.49 6.32 7.48 1.17 1.32 1.89
80+ 0.22 3.66 5.39 0.63 1.00 1.21
ASMR 3.31 20.67 25.01 4.16 4.05 6.89
95%CI 3.27–3.35 20.57–20.77 24.89–25.13 4.12–4.20 4.01–4.09 6.83–6.95
Male Number of deaths Number of deaths
19,486 94,075 98,899 19,068 8752 26,627
Age
0–14 0.00 0.01 0.02 0.02 0.00 0.00
15–39 0.10 0.53 0.62 0.12 0.03 0.16
40–59 3.07 6.50 6.34 1.60 0.51 2.52
60–69 1.76 8.53 8.29 1.79 0.69 2.35
70–79 1.02 9.38 9.84 1.76 0.90 2.26
80+ 0.43 5.11 6.75 0.81 0.70 1.30
ASMR 6.38 30.05 31.85 6.10 2.83 8.60
95%CI 6.28–6.48 29.85–30.25 31.83–31.87 6.02–6.18 2.77–2.89 8.50–8.70
Female Number of deaths Number of deaths
3678 6,5190 94,533 12,458 23,263 25,734
Age
0–14 0.00 0.01 0.01 0.01 0.00 0.00
15–39 0.01 0.43 0.54 0.08 0.03 0.09
40–59 0.36 2.86 4.26 0.63 0.86 1.25
60–69 0.22 3.33 4.76 0.68 1.26 1.40
70–79 0.17 4.41 5.99 0.78 1.58 1.65
80+ 0.12 2.98 4.75 0.55 1.14 1.16
ASMR 0.88 14.02 20.31 2.73 4.88 5.56
95%CI 0.86–0.90 13.90–14.14 20.17–20.45 2.67–2.79 4.82–4.94 5.48–5.64
Trends in GI cancer mortality
decreased with relative constancy from 23.5 to 19.6 between
1998 and 2012 (Fig. 2c). Moreover, a significant increase in the
mortality rates from 3.53 per 100,000 persons to 8.56 per 100,
000 persons was detected in males aged 40–59 years through-
out the period 1963–2012 with a slope of 0.01 (p < 0.001).
Mortality Rates and Annual Trends Between 1979
and 2012
In the analyses of mortality rates of hepatic cancer, the JP
regression depicted a basically constant period between
1979 and 1995, which was followed by a significant decrease
in mortality rates. The slopes of the segmented linear were
0.00 (p = 0.77) and -0.02 (p < 0.001), respectively (Fig. 1d).
A similar trend was observed in both male and female mor-
tality rates for hepatic cancer (Fig. 2d).
Fig. 1 Results of fitted segmented lines of annual Hungarian age-standardizedmortality rates for esophageal cancer a, gastric cancer b, colorectal cancer
c, hepatic cancer d, cancer of the gallbladder e and pancreatic cancer f using joinpoint regression models
Table 2 Risk of mortality from gastrointestinal cancers in male groups
as compared with females
Risk 95 % confidence interval
Esophageal cancer 7.25 5.29–9.96
Gastric cancer 2.07 1.90–2.26
Colorectal cancer 1.55 1.43–1.68
Hepatic cancer 2.28 1.85–2.80
Cancer of the gallbladder 0.58 0.47–0.72
Pancreatic cancer 1.60 1.37–1.86
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The overall mortality rates of cancer of the gallbladder
remained unchanged until 1988. Since then significant de-
creasing trends have been observed with slopes of −0.02
(p < 0.001) and 0.04 (p < 0.001) in the periods of 1988–
1997 and 1997–2012, respectively (Fig. 1e). Similar changes
were detected in the gender-specific analyses, which depicted
turning points in 1989 and 1997 for females and in 1988 and
1998 for males, and changes in segmented linear trends
(Fig. 2e). The slopes of the segments in the female cases were
−0.01 (p < 0.07) for 1979–1989, −0.04 (p < 0.001) for 1989–
1997 and -0.05 (p < 0.001) for 1997–2012, and in the male
cases were 0.01 (p = 0.28) for 1979–1988, −0.01 (p = 0.32) for
1988–1997 and −0.03 (p = <0.001) for 1997–2012.
There was an increasing trend in the mortality rates of
pancreatic cancer between 1979 and 2012, but the JP regres-
sion model fitted a non-significantly decrease between 1998
and 2001, indicating a significantly increasing linear trend
from 1979 to 1998, and then a rather non-constant level be-
tween 1998 and 2001, followed by a significant increase from
2001 to 2012 (the slopes of the three segments: 0.01
(p < 0.001), −0.03 (p = 0.53) and 0.01 (p < 0.001), respective-
ly; Fig. 1f). Very similar trends in mortality rates of pancreatic
cancer were found in the gender-specific analyses for both
female and male cases (Fig. 2f). Furthermore, a significant
increase in mortality rate from 2.70 per 100,000 persons to
4.25 per 100,000 persons was detected in males aged 40–
Fig. 2 Gender-specific results of fitted segmented lines of annual Hungarian age-standardized mortality rates for esophageal cancer a, gastric cancer b,
colorectal cancer c, hepatic cancer d, cancer of the gallbladder e and pancreatic cancer f using joinpoint regression models
Trends in GI cancer mortality
59 years throughout the period 1979–2012, with a slope of
0.01 (p < 0.001).
Discussion
Main Findings
The mortality rate of colorectal cancer was revealed in a sig-
nificant annual increase until 1998, followed by a significant
decrease until 2006, and a basically constant period thereafter
and an increasing trend in the mortality rate of pancreatic
cancer was observed during the whole study period.
However, the mortality risks of colorectal and pancreatic can-
cers increased in males aged 40–59 years during the study
period as compared with other age groups. Similarly, increas-
ing mortality esophageal and the other gastrointestinal cancers
were found in the groups aged 40–59 years and 70–79 years
relative to the other age groups, respectively. Nevertheless,
significantly higher risks of gastrointestinal cancer-related
deaths were observed in males as compared with females ex-
cept death related to cancer of the gallbladder.
The annual mortality rates of gastric and gallbladder cancer
decreased throughout the study period. Furthermore, a decline
in mortality from esophageal and hepatic cancers was found
since 1998 and 1995, respectively. However, our results re-
vealed that the mortality rates of colorectal and pancreatic
cancer have been increasing in the past few years.
Summarizing, our study describes the pattern of trends in
mortality rates of gastointestinal cancers in Hungary during
the study period.
Strengths and Limitations
Instead of reporting only the ASMRs, we applied regression
models to estimate the trends in the mortality rates of gastro-
intestinal cancers in Hungary between 1963 and 2012, includ-
ing JP regression, which involves the best fit of the segmented
lines connected at the Bjoinpoints^ (turning points) through
use of a Poisson model of variation [8]. As far as we know,
this was the first utilization of JP regression to investigate the
pattern of trends in gastrointestinal cancers in Hungary.
Although ASMRs of gastrointestinal cancers in Hungary
have been investigated previously, detailed statistics have
been only reported rarely.
We also estimated the risk of gastrointestinal cancer-related
death by using population data. Due to the lack of available
data, only gender-specific analyses were investigated.
However, this study investigated a 50-year period, which is
one of the longest study periods subjected to the analysis of
trends in cancer mortality of the digestive organs.
Data were obtained from civil registers, which could have
been influenced by a certain simplification of categorization
during the 50-year interval of the study, but we are confident
that our results do reflect real trends.
Comparison with Other Studies
A number of studies have been reported to investigate trends
in cancer incidence and mortality in different geographical
areas [9–11]. Furthermore, in most countries, trends in total
cancer mortality were more favorable in middle-aged popula-
tions than in Hungary.
Similarly to other studies, our findings confirm declines in
gastric, esophageal and gallbladder cancer mortality, and in-
creases in pancreatic and colorectal cancer mortality [12, 13].
Levi et al. reported age-standardized mortality rates per
100,000 men/women for selected cancers in the 17 member
countries of the European Union and the eight acceding coun-
tries in 2000 [12]. Although all central and eastern accession
countries had exceedingly high rates, ranking from 1 to 8, the
Hungarian total mortality rate was the highest in men and the
second highest in women. Nevertheless, the Hungarian mor-
tality rates of 8.58, 33.51 and 10.74 per 100,000 men from
esophageal, colorectal and pancreas cancers were the highest
among the 25 countries, respectively.
Colorectal cancer is the second most common cause of
cancer mortality in men worldwide and in Hungary [5, 14].
Similarly to other studies [5, 6, 14], we found a significantly
higher risk of colorectal cancer mortality in males, which was
more marked in the group aged 40–59 years. Colorectal can-
cer is one of the most preventable of cancers if competent
screening is used. The results of one study demonstrated a
strong linear relationship between the country-specific
mortality-to-incidence ratio (MIR) for colorectal cancer and
health system ranking in all Organization for Economic
Cooperation and Development (OECD) countries [15] and
Hungary was ranked top both in the incidence rate and in
the mortality rate of colorectal cancer in 2012. Nevertheless,
countries with an MIR below the predicted MIR appear to be
more likely to have formal colorectal cancer screening guide-
lines that are acted on across a variety of health care settings.
Mortality rates from colorectal cancer were higher in
Czech Republic than in Hungary at the beginning of the 21st
century, but the Czech mortality rate decreased significantly
during the decade after the screening of fecal immunochemi-
cal testing and fecal occult blood testing were introduced [15].
Gastric cancer is the fourth most common malignant tumor
in Hungary [16]. The gastric cancer mortality rate is also high,
but not the highest among the countries in the European
Union. The reported mortality rates were higher in the Baltic
states, Croatia and Portugal than in Hungary in 2009 [17]. In
spite of the decrease revealed in this study, considerable edu-
cational and socioeconomic inequalities were reported in can-
cer mortality, particularly for gastric cancer among males [18].
Moreover, further declines in gastric cancer mortality rates
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may be achieved with through the control of the known risk
factors, including Helicobacter pylori infection, tobacco con-
sumption and diet [19].
Pancreatic cancer ranks the fifth and sixth most common
cancer in men and women, respectively, and has the lowest 5-
year survival rate of any gastrointestinal tumor [4, 20].
Advancing age is a risk factor for pancreatic cancer, with
80 % of cases occurring in patients 60 to 80 years of age.
However, pancreatic cancer-related mortality has been in-
creasing in Hungary since 2001 and 1979 overall and in males
aged 40–59 years, respectively. Nevertheless, the Hungarian
pancreatic cancer mortality rate was also ranked top in the
countries of the European Union in 2012 [12].
An increase in the incidence of esophageal cancer has been
reported in some European countries [4, 21, 22], though a
decline in the mortality from esophageal cancer was observed
in our study. However, in spite of the favorable decline in
mortality rates from esophageal cancer in Hungary, the age-
standardized mortality rates at all ages and truncated at 25–49
and 35–64 years are still ranked first in the member countries
of the European Union during the period 2000–2009 [23].
Gallbladder cancer is one of the few malignancies that is
more common in females than in males [11, 24]. However, in
spite of the favorable decline in mortality rates from cancer of
the gallbladder in Hungary, the age-standardized mortality
rates are still ranked high in the member countries of the
European Union during the period 2000–2009 [4].
International variation in liver cancer rates is largely ex-
plained by the distribution of chronic hepatitis B virus
(HBV) and hepatitis C virus (HCV) infections and these two
viruses account for 78% (HBV, 53%; HCV, 25%) of the total
liver cancer deaths globally. [5, 25] Liver cancer is much more
common in males than in females, and the liver cancer inci-
dence rates for both men and women increased significantly
from 1993 to 2002 in the economically developed countries of
Western Europe [26]. In contrast, the mortality rates of hepatic
cancer have been decreasing in both males and females in
Hungary since 1995 and became lower than the average mor-
tality rate of liver cancer in the European Union in 2012 [4].
Conclusions
Gastrointestinal cancers are global health problem with unac-
ceptably high mortality due to the advanced state of most of
the cases at diagnosis. The presented data suggest that
Hungarian mortality rates are particularly high. The detection
of gastrointestinal cancers at an early stage would significantly
improve the outcome of these malignancies. The goal of can-
cer screening is to reduce mortality through a reduction in the
incidence of the advanced disease. Colorectal cancer is a good
candidate for screening, because it has detectable premalig-
nant lesions, and early treatment is beneficial. Although some
non-invasive methods are routinely used to screen for colo-
rectal cancer, endoscopy still remains the most sensitive meth-
od for the detection of early lesions [27]. Despite advances in
screening and early detection of some gastrointestinal cancers,
no reliable screening test exists for most of them. Continued
efforts are therefore needed to discover effective tests to iden-
tify patients with nonhereditary risk factors and to develop
invasive and cost-effective screening modalities.
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